1 | Additional Representation Sheet | 25 Mar 1980 |
10 | Certificate | 15 Sep 1998 |
10 | Other Documents | 15 Sep 1998 |
11 | Note Sheet | 15 Sep 1998 |
11 | TM-1 | 15 Sep 1998 |
12 | Journal Copy | 15 Sep 1998 |
13 | Examination Report | 15 Sep 1998 |
14 | Examination Report | 14 Jan 2002 |
15 | TM-R(RENEWAL OF TRADE MARK) | 23 Jul 2018 |
2 | Journal Copy | 28 Aug 1998 |
3 | Note Sheet | 28 Aug 1998 |
4 | Authorization Document (POA) | 28 Aug 1998 |
4 | Note Sheet | 28 Aug 1998 |
5 | TM-1 | 28 Aug 1998 |
6 | Certificate | 28 Aug 1998 |
7 | Additional Representation Sheet | 28 Aug 1998 |
8 | Certificate | 15 Sep 1998 |
8 | Note Sheet | 15 Sep 1998 |
9 | Other Documents | 15 Sep 1998 |
9 | TM-1 | 15 Sep 1998 |
1 | O3 NOTICE | 6396683 | 2821906 | 23 May 2018 |
2 | RENEWAL INTIMATION LETTER | 6739073 | 26 Jul 2018 |
The application for Nucondil was made on 28 August 1998.
The trademark applicant for Nucondil is EMCURE PHARMACEUTICALS.
Nucondil is applied in class(es) 5.
Application for Nucondil is on Registered stage.
Application Id allotted to Nucondil is 816835.
Trademark agent or attorney for the application is R. K. Dewan & Co.
Nucondil filed with the Intellectual property office as a WORD.